scholarly journals Breast cancer and combined oral contraceptives: results from a multinational study

1990 ◽  
Vol 61 (1) ◽  
pp. 110-119 ◽  
Author(s):  
Keyword(s):  
Breast Cancer ◽  
Oral Contraceptives ◽  
Multinational Study ◽  
Combined Oral Contraceptives

Breast cancer and combined oral contraceptives: An Italian case-control study

1989 ◽  
Vol 25 (11) ◽  
pp. 1613-1618 ◽  
Author(s):  
Carlo La Vecchia ◽  
Fabio Parazzini ◽  
Eva Negri ◽  
Peter Boyle ◽  
Antonella Gentile ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Oral Contraceptives ◽  
Case Control Study ◽  
Case Control ◽  
Combined Oral Contraceptives ◽  
Italian Case ◽  
Control Study

scholarly journals Progestin-only and combined oral contraceptives and receptor-defined premenopausal breast cancer risk: The Norwegian Women and Cancer Study

2018 ◽  
Vol 142 (11) ◽  
pp. 2293-2302 ◽  
Author(s):  
Marit Busund ◽  
Nora S. Bugge ◽  
Tonje Braaten ◽  
Marit Waaseth ◽  
Charlotta Rylander ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Breast Cancer Risk ◽  
Cancer Risk ◽  
Oral Contraceptives ◽  
Premenopausal Breast Cancer ◽  
Combined Oral Contraceptives ◽  
Cancer Study

Benefits and Risks of Combined Oral Contraceptives

1993 ◽  
Vol 32 (03) ◽  
pp. 222-224 ◽  
Author(s):  
M. P. Vessey
Keyword(s):  
Breast Cancer ◽  
Myocardial Infarction ◽  
Adverse Effect ◽  
Acute Myocardial Infarction ◽  
Oral Contraceptives ◽  
Haemorrhagic Stroke ◽  
Protective Effects ◽  
Epithelial Cancer ◽  
Combined Oral Contraceptives ◽  
Number Of Authors

Abstract:The use of combined oral contraceptives carries a number of well-established major non-contraceptive benefits. Of these, the most important protective effects are suppression of the risk of epithelial cancer of the ovary and cancer of the endometrium. Also of great importance is a reduction in the risk of pelvic inflammatory disease. Needless to say, there are also some established risks of combined oral contraceptives. The most important of these are the vascular ones, comprising effects on acute myocardial infarction, thrombotic stroke, haemorrhagic stroke, and venous thrombosis and embolism. Possible risks which are still under evaluation include an adverse effect on breast cancer and, likewise, on carcinoma of the cervix. More information is needed about both these conditions. A number of authors have provided analyses of varying degrees of complexity in which they have attempted to weigh the benefits and risks of combined oral contraceptives. Results from some of these studies are presented in the paper. On the whole, the findings are reasonably reassuring.

Invasive squamous-cell cervical carcinoma and combined oral contraceptives: Results from a multinational study

1993 ◽  
Vol 55 (2) ◽  
pp. 228-236 ◽  
Author(s):  
◽  
Geoffrey Berry ◽  
Robert Maclennan ◽  
Rodney Shearman ◽  
Tatiana Jelihovsky ◽  
...  
Keyword(s):  
Cervical Carcinoma ◽  
Oral Contraceptives ◽  
Squamous Cell ◽  
Multinational Study ◽  
Combined Oral Contraceptives ◽  
Squamous Cell Cervical Carcinoma
Sign in / Sign up

Export Citation Format

Share Document